Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Treated with diet or metformin. Stable glycemic control indicated by no changed treatment within 3 months~* Diabetes Mellitus diagnosis \<5 years~Exclusion Criteria:~* Clinically significant illness or clinically relevant trauma, as judged by the investigator, within two weeks before the first administration of the investigational product~* Clinically significant abnormalities in clinical chemistry, hematology, or urinalysis results

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Part A, arm 1 (Type: EXPERIMENTAL): 1) 8 pats: AZD6370 increasing oral single doses a+b+c+placebo together with food
- Part A, arm 2 (Type: EXPERIMENTAL): 1) 8 pats: AZD6370 increasing oral single doses a+b+c+placebo without food
- Part B, arm1, 2, and 3 (Type: EXPERIMENTAL): 1. AZD6370 dose x mg o.d.~2. dose x/2 mg b.i.d.~3. dose x/4 mg q.i.d.
- Part B, arm 4 (Type: EXPERIMENTAL): 4) Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).